Cardinal Health — Aug 12, 2025 release

Non-GAAP earnings per share $9.30 to $9.50 Pharmaceutical and Specialty Solutions segment: Revenue 11% to 13% growth Segment profit 11% to 13% growth Global Medical Products and Distribution segment: Revenue 2% to 4% growth Segment profit At least $140 million Other (NPHS, at-Home Solutions, OptiFreight Logistics): Revenue 26% to 28% growth Segment profit 25% to 27% growth Interest and other ~$275 million Non-GAAP effective tax rate 22.0% - 24.0% Diluted weighted average shares outstanding 238 million to 240 million Share repurchases ~$750 million Capital Expenditures ~$600 million Non-GAAP adjusted free cash flow $2.75 billion to $3.25 billion Bold indicates a change to the preliminary FY26 outlook provided in the Investor Day press release on June 12, 2025. The increase to non-GAAP diluted EPS reflects a benefit to net earnings of classifying the shares held by physicians and management of The Specialty Alliance as a liability as opposed to non-controlling interests within equity and increased contributions from the Pharmaceutical and Specialty Solutions segment and the growth businesses reported in Other. 3 Recent highlights • Cardinal Health hosted an Investor Day on June 12th, 2025 where management detailed the company's momentum, growth strategies and updated long-term value creation plans • Cardinal Health announced that the company entered into a definitive agreement to acquire Solaris Health, the country’s leading urology MSO with over 750 providers. Solaris Health will join the Specialty Alliance’s Urology Alliance and advances Cardinal Health’s multi-specialty growth strategy • Cardinal Health hosted its 33 rd annual Retail Business Conference, bringing together approximately 5,000 attendees from across the country to celebrate the critical role its independent pharmacy customers play in caring for their commu